Discovery & Development

In 2014, the Ice Bucket Challenge raised millions; eight years on, we have an FDA-approved therapy

Pharma must ask itself how it will contribute to the fight against women’s mental health challenges.

Researchers examine how changes in the gut – including those that result from posture – affect drug bioavailability.

How global collaborations are inching us toward a victory over a neglected parasitic disease

Keith Horspool reflects on the efforts that led the FDA to launch its pilot review program for novel excipients

Can AI usher in a new age of medicine or is it all hype? In this blog, we go down the rabbit hole.

As new treatment modalities emerge, drug developers are turning to synthetic chemistry – and partners like Veranova.

Based in Barcelona and Belgium, this startup company is bringing small molecules to the fight against X-linked leukodystrophy

How can new analytical tech help biopharma manufacturers?

The cell cycle can be used to shut down cancer’s survival mechanisms, but what does it take to turn that knowledge into a medicine?